Circulating platelet-derived vesicle in atrial fibrillation
Article Sidebar
Main Article Content
Abstract
Platelet vesiculation is common factor contributing in coagulation and thromboembolism in patients with atrial fibrillation (AF). Platelet-derived vesicles are involved in the coagulation, thromboembolism, microvascular inflammation, arterial stiffness, vascular calcification, atherosclerotic plaque shaping and rupture, endothelial dysfunction, cardiac remodelling, and kidney dysfunction. Recent clinical studies have revealed elevated concentrations of platelet-derived vesicles in peripheral blood of patients with current AF and history of AF. The aim of the mini review is to discuss the role of platelet-derived micro vesicles as predictive biomarker in AF. Serial measures of circulating levels of platelet-derived vesicules are discussed to be useful in stratification of AF patients at risk of thromboembolic complications, but there is limiting evidence regarding their predictive value that requires further investigations in large clinical trials.
Article Details
Copyright (c) 2019 Berezin AE, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Shanmuganathan M, Vughs J, Noseda M, Emanueli C. Exosomes: Basic Biology and Technological Advancements Suggesting Their Potential as Ischemic Heart Disease Therapeutics. Front Physiol. 2018; 9: 1159. Ref.: https://tinyurl.com/yxa5gxag
Berezin A, Zulli A, Kerrigan S, Petrovic D, Kruzliak P. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases. Clin Biochem. 2015; 4: 562-568. Ref.: https://tinyurl.com/yyf9f8ds
Nawaz M, Shah N, Zanetti BR, Maugeri M, Silvestre RN, et al. Extracellular Vesicles and Matrix Remodeling Enzymes: The Emerging Roles in Extracellular Matrix Remodeling, Progression of Diseases and Tissue Repair. Cells. 2018; 7. Ref.: https://tinyurl.com/y4ouroko
La Marca V, Fierabracci A. Insights into the Diagnostic Potential of Extracellular Vesicles and Their miRNA Signature from Liquid Biopsy as Early Biomarkers of Diabetic Micro/Macrovascular Complications. Int J Mol Sci. 2017; 18. Ref.: https://tinyurl.com/y5jexz6r
Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV. Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation. BBA Clin. 2015; 4: 69-75. Ref.: https://tinyurl.com/y3jb5jdj
Caporali A, Martello A, Miscianinov V, Maselli D, Vono R, et al. Contribution of pericyte paracrine regulation of the endothelium to angiogenesis. Pharmacol Ther. 2017; 171: 56-64. Ref.: https://tinyurl.com/y5jn9uel
De Toro J, Herschlik L, Waldner C, Mongini C. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol. 2015; 6: 203. Ref.: https://tinyurl.com/y3cxpv8a
Berezin AE. Microparticles in Chronic Heart Failure. Adv Clin Chem. 2017; 81: 1-41. Ref.: https://tinyurl.com/y3v76f6l
Berezin AE, Kremzer AA, Cammarota G, Zulli A, Petrovic D, et al. Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure. Clin Chem Lab Med. 2016; 54: 1259-1267. Ref.: https://tinyurl.com/yxtq8m22
Chen BY, Sung CW, Chen C, Cheng CM, Lin DP, et al. Advances in exosomes technology. Clin Chim Acta. 2019; 493:14-19. Ref.: https://tinyurl.com/y37eudtp
Juan T, Fürthauer M. Biogenesis and function of ESCRT-dependent extracellular vesicles. Semin Cell Dev Biol. 2018; 74: 66-77. Ref.: https://tinyurl.com/yxwl6syy
Hervera A, Santos CX, De Virgiliis F, Shah AM, Di Giovanni S. Paracrine Mechanisms of Redox Signalling for Postmitotic Cell and Tissue Regeneration. Trends Cell Biol. 2019; 29: 514-530. Ref.: https://tinyurl.com/yyxmmqb7
Mobarak H, Heidarpour M, Lolicato F, Nouri M, Rahbarghazi R, et al. Physiological impact of extracellular vesicles on female reproductive system; highlights to possible restorative effects on female age-related fertility. Biofactors. 2019; 45: 293-303. Ref.: https://tinyurl.com/y35o3nt2
Navarro A, Molins L, Marrades RM, Moises J, Viñolas N, et al. Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery. Cancers. 2019; 11. Ref.: https://tinyurl.com/y5lxo9ux
Aslan C, Maralbashi S, Salari F, Kahroba H, Sigaroodi F, et al. Tumor-derived exosomes: Implication in angiogenesis and antiangiogenesis cancer therapy. J Cell Physiol. 2019. Ref.: https://tinyurl.com/y4qgmaet
Yang L, Zhu J, Zhang C, Wang J, Yue F, et al. Stem cell-derived extracellular vesicles for myocardial infarction: a meta-analysis of controlled animal studies. Aging (Albany NY). 2019; 11: 1129-1150. Ref.: https://tinyurl.com/y48bbwz5
Bei Y, Das S, Rodosthenous RS, Holvoet P, Vanhaverbeke M, et al. Extracellular Vesicles in Cardiovascular Theranostics. Theranostics. 2017; 7: 4168-4182. Ref.: https://tinyurl.com/yxadvxs7
Kenari AN, Kastaniegaard K, Greening DW, Shambrook M, Stensballe A, et al. Exosome-mimetic nanovesicles contain distinct proteome and post-translational modified protein cargo, in comparison to exosomes. Proteomics. 2019; e1800161.
Vagner T, Chin A, Mariscal J, Bannykh S, Engman D, et al. Protein composition reflects extracellular vesicle heterogeneity. Proteomics. 2019; 19: e1800167. Ref.: https://tinyurl.com/y5mdty6d
Aatonen M, Valkonen S, Böing A, Yuana Y, Nieuwland R, et al. Isolation of Platelet-Derived Extracellular Vesicles. Methods Mol Biol. 2017; 1545: 177-188. Ref.: https://tinyurl.com/y4szfu9h
Hedley BD, Llewellyn-Smith N, Lang S, Hsia CC, MacNamara N, et al. Combined accurate platelet enumeration and reticulated platelet determination by flow cytometry. Cytometry B Clin Cytom. 2015; 88: 330-337. Ref.: https://tinyurl.com/yxmpworn
Bennett JS. The molecular biology of platelet membrane proteins. Semin Hematol. 1990; 27: 186–204. Ref.: https://tinyurl.com/y2235ydv
Clemetson KJ, Clemetson JM. Platelet GPIb complex as a target for anti-thrombotic drug development. Thromb Haemost. 2008; 99: 473-479. Ref.: https://tinyurl.com/y42x8bgg
Chevillet JR, Kang Q, Ruf IK, Briggs HA, Vojtech LN, Hughes SM, et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci. 2014; 111: 14888-14893. Ref.: https://tinyurl.com/y5nd5yax
Van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. Classification, Functions, and Clinical Relevance of Extracellular Vesicles. Pharmacological Reviews. 2012; 64: 676-705. Ref.: https://tinyurl.com/yyfpe9eb
Liu C, Zhao J, Tian F, Chang J, Zhang W, Sun J. λ-DNA and Aptamer Mediated Sorting and Analysis of Extracellular Vesicles. J Am Chem Soc. 2019.
Nolan JP, Jones JC. Detection of platelet vesicles by flow cytometry. Platelets. 2017; 28: 256-262. Ref.: https://tinyurl.com/y4y22qwm
Lacroix R, Robert S, Poncelet P, Kasthuri R, Key N, et al. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost. 2010; 8: 2571-2574. Ref.: https://tinyurl.com/y6au77ef
Tao SC, Guo SC, Zhang CQ. Platelet-derived Extracellular Vesicles: An Emerging Therapeutic Approach. Int J Biol Sci. 2017; 13: 828-834. Ref.: https://tinyurl.com/y25zsu24
Zaldivia MTK, Hering D, Marusic P, Sata Y, Lee R, et al. Successful Renal Denervation Decreases the Platelet Activation Status in Hypertensive Patients. Cardiovasc Res. 2019. Ref.: https://tinyurl.com/y5stksbw
Zaldivia MT, Rivera J, Hering D, Marusic P, Sata Y, et al. Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk. Hypertension. 2017; 69: 323-331. Ref.: https://tinyurl.com/yyrrpyog
Barnes JN, Harvey RE, Miller KB, Jayachandran M, Malterer KR. et al. Cerebrovascular Reactivity and Vascular Activation in Postmenopausal Women with Histories of Preeclampsia. Hypertension. 2018; 71: 110-117. Ref.: https://tinyurl.com/y2jjomjg
Van Wijk MJ, Van Bavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res. 2003; 59: 277-287. Ref.: https://tinyurl.com/yycsgewz
Yano Y, Kambayashi J, Shiba E, Sakon M, Oiki E. et al. The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem J. 1994; 299: 303-308. Ref.: https://tinyurl.com/y4fc4acw
Gemmel CH, Sefton MV, Yeo E. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann’s thrombasthenia defect. J Biol Chem. 1993; 268: 14586-14589. Ref.: https://www.ncbi.nlm.nih.gov/pubmed/8325838
Cauwenberghs S, Feijge MA, Harper AG, Sage SO, Curvers J, Heemskerk JW. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett. 2006; 580: 5313-5320. Ref.: https://tinyurl.com/y3za2dbw
Nomura S, Komiyama Y, Miyake T, Miyazaki Y, Kido H. et al. Amyloid-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost. 1994; 72: 519-522. Ref.: https://tinyurl.com/y3ns39f8
Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med. 2004; 10: 171-8. Ref.: https://tinyurl.com/y5bnadm5
Barry OP, Practico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest. 1997; 99: 2118-2127. Ref.: https://tinyurl.com/y22um7yp
Garcia B, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF. The platelet particle proteome. J Proteome Res. 2005; 4: 1516-1521. Ref.: https://tinyurl.com/y4vrf9w3
Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood. 2008; 111: 5028–5036. Ref.: https://tinyurl.com/y4gymbr8
Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation. 2002; 106: 1962-1967. Ref.: https://tinyurl.com/y5aapoc3
Siwaponanan P, Keawvichit R, Udompunturak S, Hunnangkul S, Reesukumal K, et al. Altered profile of circulating microparticles in nonvalvular atrial fibrillation. Clin Cardiol. 2019; 42: 425-431. Ref.: https://tinyurl.com/y5mf3552 w
Jesel L, Abbas M, Toti F, Cohen A, Arentz T, et al. Microparticles in atrial fibrillation: a link between cell activation or apoptosis, tissue remodelling and thrombogenicity. Int J Cardiol. 2013; 168: 660-669. Ref.: https://tinyurl.com/y699dx4g
Horstman LL, Jy W, Bidot CJ, Nordberg ML, Minagar A, et al. Potential roles of cell-derived microparticles in ischemic brain disease. Neurol Res. 2009; 31: 799-806. Ref.: https://tinyurl.com/yysq8hav
Choudhury A, Chung I, Blann AD, Lip GYH. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. Chest. 2007; 131: 809-815. Ref.: https://tinyurl.com/y562s9lz
Choudhury A, Chung I, Blann AD, Lip GY. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. J Am Coll Cardiol. 2007; 49: 1957-1964. Ref.: https://tinyurl.com/y3olruzu
Tan KT, Tayebjee MH, Lim HS, Lip GY. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet micro particle levels. Diabet Med. 2005; 22: 1657-1662. Ref.: https://tinyurl.com/y34kflz8
Kamath S, Blann AD, Chin BS, Lanza F, Aleil B, et al. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. Eur Heart J. 2002; 23: 1788-1795. Ref.: https://tinyurl.com/y4df4c72
Choudhury A, Chung I, Blann A, Lip GY. Platelet adhesion in atrial fibrillation. Thromb Res. 2007; 120: 623-629. Ref.: https://tinyurl.com/yxdmn3ry